Soaring U.K. energy costs top drug manufacturers concerns; Canada cuts OTC red tape;

 @EricPFierce: Genzyme says the FDA and EMA have signed off a second fill-finish operation for a couple of drugs at the upgraded plant in Ireland. Report | Follow @EricPFierce

> Soaring energy costs in the U.K. top the list of concerns for drug and chemical manufacturers there, according to a survey by a trade association. Story

> The U.K.'s Medicines and Healthcare products Regulatory Agency says it has a new plan for protecting consumers and fighting counterfeit drugs from getting into the authorized supply chain. News

> Almac has installed a blister line at its new plant in Audobon, PA. that is capable of producing 12,000 blister packs an hour in a series of sizes. Item

> Canada is eliminating a regulatory process, which will cut about a year out of the time it takes to move a branded drug to over-the-counter designation after its been given approval. More

> AMRI is expanding its contract manufacturing and outsourcing efforts. Article


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.